Characterization and analysis of human arterial tissue secretome by 2-DE and nLC-MS/MS.

[1]  E. Calvo,et al.  Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. , 2012, Journal of proteomics.

[2]  Mehdi Mirzaei,et al.  Less label, more free: Approaches in label‐free quantitative mass spectrometry , 2011, Proteomics.

[3]  L. R. Padial,et al.  A Proteomic Focus on the Alterations Occurring at the Human Atherosclerotic Coronary Intima* , 2011, Molecular & Cellular Proteomics.

[4]  H. Peeters,et al.  Human Plasma Glycome in Attention-Deficit Hyperactivity Disorder and Autism Spectrum Disorders* , 2010, Molecular & Cellular Proteomics.

[5]  F. Vivanco,et al.  An optimum method designed for 2‐D DIGE analysis of human arterial intima and media layers isolated by laser microdissection , 2009, Proteomics. Clinical applications.

[6]  J. Eng,et al.  Proteomics Analysis of Human Coronary Atherosclerotic Plaque , 2007, Molecular & Cellular Proteomics.

[7]  B. Wolffenbuttel,et al.  Characterization of the Human Visceral Adipose Tissue Secretome*S , 2007, Molecular & Cellular Proteomics.

[8]  J. Egido,et al.  Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients. , 2006, Journal of the American Society of Nephrology : JASN.

[9]  J. Michel,et al.  Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis , 2004, Circulation.

[10]  J. Michel,et al.  Proteomic analysis of human vessels: Application to atherosclerotic plaques , 2003, Proteomics.

[11]  E. Topol,et al.  Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. , 2003, Physiological genomics.

[12]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.